(Q73462083)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

S W Van Gool

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Van Kerschaver

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Brock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F Hulstaert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Vanmechelen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Uyttebroeck

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Van De Voorde

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Vanderstichele

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

2076-2084

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187896%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2401934

4 November 2019

exact match

0 references

cites work

Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

The cerebrospinal fluid and plasma concentrations of gamma-trace and beta2-microglobulin at various ages and in neurological disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Are cognitive and educational development affected by age at which prophylactic therapy is given in acute lymphoblastic leukaemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Central Nervous System Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Identification of leukemic cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Myeloblastoma of the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Reversible steroid dementia in patients without steroid psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Phenytoin prevents stress‐ and corticosterone‐induced atrophy of CA3 pyramidal neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Effects of glucocorticoids on hippocampal long-term potentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Interactions of steroid, methotrexate, and radiation determine neurotoxicity in an animal model to study therapy for childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Neurotoxicity associated with systemic high-dose cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Changes in drug delivery (by blood-brain barrier dysfunction) on arachnoid leukemia: implication for CNS leukemic dissemination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

Chemotherapy for acute lymphocytic leukemia: cognitive and academic sequelae

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021

CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401934

7 January 2021